Phreesia Past Earnings Performance
Past criteria checks 0/6
Phreesia's earnings have been declining at an average annual rate of -24.4%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 26.2% per year.
Key information
-24.4%
Earnings growth rate
58.3%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 26.2% |
| Return on equity | -54.4% |
| Net Margin | -38.4% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Apr 12
Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)
Feb 16Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth
Jan 04Is Phreesia Finally Turning The Corner?
Dec 07Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?
Oct 25Phreesia: Share Price Dip Is A Buying Opportunity
Sep 21Phreesia: Strong Execution Should Continue To Drive Growth
Jul 11Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion
May 18Phreesia: Strong Growth Momentum With Expanded TAM
Jan 28Phreesia - Healthcare Ecosystem At An Attractive Valuation
Dec 13Phreesia Q3 2023 Earnings Preview
Dec 07Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M
Sep 07Phreesia: Their Time Has Passed
May 10Opportunistic Time To Buy Phreesia's Healthcare Disruption
Dec 27Are Phreesia, Inc. (NYSE:PHR) Investors Paying Above The Intrinsic Value?
Nov 08Is It Time To Consider Buying Phreesia, Inc. (NYSE:PHR)?
Sep 15Phreesia (PHR) Investor Presentation - Slideshow
Jun 16Revenue & Expenses BreakdownBeta
How Phreesia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 24 | 356 | -137 | 222 | 112 |
| 31 Oct 23 | 338 | -144 | 228 | 108 |
| 31 Jul 23 | 319 | -152 | 228 | 102 |
| 30 Apr 23 | 301 | -162 | 228 | 97 |
| 31 Jan 23 | 281 | -176 | 232 | 91 |
| 31 Oct 22 | 262 | -185 | 234 | 83 |
| 31 Jul 22 | 245 | -181 | 228 | 76 |
| 30 Apr 22 | 228 | -158 | 208 | 65 |
| 31 Jan 22 | 213 | -118 | 174 | 52 |
| 31 Oct 21 | 197 | -80 | 140 | 41 |
| 31 Jul 21 | 180 | -50 | 111 | 32 |
| 30 Apr 21 | 164 | -32 | 93 | 26 |
| 31 Jan 21 | 149 | -27 | 83 | 23 |
| 31 Oct 20 | 140 | -23 | 77 | 21 |
| 31 Jul 20 | 134 | -19 | 71 | 20 |
| 30 Apr 20 | 130 | -83 | 67 | 19 |
| 31 Jan 20 | 125 | -91 | 63 | 19 |
| 31 Oct 19 | 118 | -102 | 57 | 18 |
| 31 Jul 19 | 110 | -113 | 54 | 17 |
| 30 Apr 19 | 104 | -54 | 49 | 16 |
| 31 Jan 19 | 100 | -45 | 46 | 14 |
| 31 Jan 18 | 80 | -38 | 44 | 11 |
Quality Earnings: PHR is currently unprofitable.
Growing Profit Margin: PHR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHR is unprofitable, and losses have increased over the past 5 years at a rate of 24.4% per year.
Accelerating Growth: Unable to compare PHR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PHR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: PHR has a negative Return on Equity (-54.44%), as it is currently unprofitable.